Introduction: The plasma concentration of beta-amyloid (Aβ) has been considered another biomarker of Alzheimer's disease and was reportedly associated with cortical Aβ accumulation.
Methods: We analyzed 28 subjects with apolipoprotein E4 (ApoE4; E4 group) and 89 subjects without ApoE4 (non-E4 group) to determine the association between cortical Aβ accumulation by standard uptake value ratio with [F]florbetapir positron emission tomography and plasma Aβ and Aβ.
Results: Aβ/Aβ correlated significantly with mean regional [F]florbetapir standard uptake value ratio in the non-E4 group ( = 0.06, = .02) but not in the E4 group, and receiver operating characteristic curve analysis for Aβ/Aβ in the non-E4 group showed sensitivity (92.9%) and specificity (45.9%) with a cutoff value of 0.150 for Aβ positivity.
Discussion: We verified that the correlation between Aβ/Aβ and Aβ accumulation differed according to ApoE phenotype. The high sensitivity of plasma Aβ/Aβ for Aβ positivity in non-E4 subjects indicated a possible role of plasma Aβ/Aβ as a screening biomarker before amyloid positron emission tomography in clinical settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614760 | PMC |
http://dx.doi.org/10.1016/j.dadm.2017.08.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!